Arrakis website screenshot

Arrakis

Arrakis Therapeutics is a biopharmaceutical company pioneering RNA-targeted small molecules (rSMs) as a new class of genetic medicines. Its rSM platform enables orally available small molecules to bind RNA and modulate previously undruggable biological pathways, with an industrialized discovery toolkit spanning multiple modalities. The lead proprietary program targets Type 1 Myotonic Dystrophy (DM1) at the root cause of the disease, alongside a pipeline of proprietary and partnered programs. A GV (Google Ventures) portfolio company in the life-sciences sector, Arrakis was added to the API Evangelist network as a company profile; it publishes a corporate and scientific website but no public developer API surface.

Arrakis is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Pharmaceuticals, and RNA.

Arrakis’ developer surface includes engineering blog, support, and 3 more developer resources.

8.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyLife SciencesBiotechnologyPharmaceuticalsRNADrug DiscoveryGenetic MedicineTherapeutics

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 8.8/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/arrakis: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Arrakis Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Company 3

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: arrakis
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/arrakis.png
name: Arrakis
description: Arrakis Therapeutics is a biopharmaceutical company pioneering RNA-targeted small molecules (rSMs) as a new class
  of genetic medicines. Its rSM platform enables orally available small molecules to bind RNA and modulate previously undruggable
  biological pathways, with an industrialized discovery toolkit spanning multiple modalities. The lead proprietary program
  targets Type 1 Myotonic Dystrophy (DM1) at the root cause of the disease, alongside a pipeline of proprietary and partnered
  programs. A GV (Google Ventures) portfolio company in the life-sciences sector, Arrakis was added to the API Evangelist
  network as a company profile; it publishes a corporate and scientific website but no public developer API surface.
url: https://raw.githubusercontent.com/api-evangelist/arrakis/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Life Sciences
- Biotechnology
- Pharmaceuticals
- RNA
- Drug Discovery
- Genetic Medicine
- Therapeutics
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/arrakis-domain-security.yml
- type: Website
  url: https://arrakistx.com
- type: About
  url: https://arrakistx.com/about/
- type: Blog
  url: https://arrakistx.com/news/
- type: Support
  url: https://arrakistx.com/contact/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence